One such miRNA is miR-502e, which is reported to act as a tumour suppressor factor by altering cell proliferation in hepatoma cell lines and hepatocellular carcinoma by targeting NIK, thereby modulating the activity of non-canonical NF-κB signalling [243]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.